Clinical Takeaway In this pilot study, short-term low-dose oral CBD did not improve glucose tolerance or meaningfully alter gut microbiome composition in sedentary adults with overweight or obesity. While epidemiological data suggest...
Research claims compounds found in cannabis could reverse disease that affects one-third of adults
✦ New CED Clinical Relevance #72 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchSafetyTHC Clinical Summary This article reports on UC San Francisco research investigating whether cannabis compounds...
Cannabis compounds could reverse disease affecting one-third of adults – New York Post
✦ New CED Clinical Relevance #72 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchCBDAgingSafety Clinical Summary Clinical Summary Recent research indicates that non-psychoactive cannabis compounds may have therapeutic...
Drugs inhibiting cannabinoid receptor type-1 can reduce obesity-associated steatohepatitis
Cannabinoid receptor type 1 antagonist inhibits progression of obesity‐associated nonalcoholic steatohepatitis in a mouse model by remodulating immune system disturbances In Summary: Steatohepatitis, a condition often associated with type 2 diabetes and...